British regulatory body: AstraZeneca blood clot risk ‘very small’

0
A health worker holds a vial of AstraZeneca's Coronavirus vaccine at the vaccination centre at Messe Dresden convention centre during a vaccination campaign. Photo: Robert Michael/dpa-Zentralbild/dpa
A health worker holds a vial of AstraZeneca's Coronavirus vaccine at the vaccination centre at Messe Dresden convention centre during a vaccination campaign. Photo: Robert Michael/dpa-Zentralbild/dpa

(dpa) – Of the more than 18 million AstraZeneca coronavirus vaccine doses administered in Britain, only around 30 cases of blood clots have occurred, British medical regulatory body MHRA announced on Saturday.

The agency described the risk of blood clots associated with the vaccine as “very small.”

As of March 24, a total of 22 cases of cerebral vein thrombosis and eight other types of thrombosis had been reported, the agency said.

Another document from the authority listed a total of 24 cases of cerebral vein thrombosis, without providing details about the discrepancy.

“On the basis of this ongoing review, the benefits of the vaccines against COVID-19 continue to outweigh any risks and you should continue to get your vaccine when invited to do so,” the regulator said.

In total, more than 31 million people in Britain have received the first dose of the vaccination, more than 18 million of them with AstraZeneca.

The number of cases has improved significantly, with the seven-day incidence figure at 55 per 100,000 inhabitants.

Send your news stories to newsghana101@gmail.com and via WhatsApp on +233 244244807 Follow News Ghana on Google News

LEAVE A REPLY

Please enter your comment!
Please enter your name here